We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about the LEEP procedure, its effectiveness in removing precancerous cervical cells, and its impact on your risk of developing cervical cancer. Understand the factors that influence recurrence and the importance of follow-up care.

Cervical cancer, a serious condition, originates in the cervix, the lower, narrow part of the uterus. In India, like in many parts of the world, awareness and early detection are crucial for managing this disease. Researchers estimate that a significant number of new cases are diagnosed annually, highlighting the importance of understanding risk factors and preventive measures. The Human Papillomavirus (HPV) is the primary culprit, responsible for over 90% of cervical cancers. Regular screening and vaccination are key to combating this infection and its potential consequences.
The Loop Electrosurgical Excision Procedure, commonly known as LEEP, is a medical intervention designed to remove precancerous cells from the cervix. These precancerous changes are medically termed as Cervical Intraepithelial Neoplasia (CIN). LEEP utilizes a thin wire loop charged with an electrical current to precisely excise the abnormal tissue. This procedure is a vital step in preventing the progression of CIN to invasive cervical cancer. It's important to understand that LEEP itself is a treatment aimed at reducing your risk, not increasing it.
A common concern after undergoing a LEEP procedure is whether it increases the risk of developing cervical cancer. The good news is that a LEEP, when performed effectively, does not inherently increase your risk of cervical cancer. In fact, its primary purpose is to eliminate precancerous cells, thereby lowering your future risk. However, it's crucial to understand that in a small percentage of cases, precancerous cells might persist or recur after the procedure. This is why follow-up care and monitoring are essential.
While LEEP is highly effective, certain factors can influence the likelihood of CIN persisting or recurring. Research indicates that the presence of 'positive margins' and an active Human Papillomavirus (HPV) infection are significant contributors. A margin refers to the surrounding healthy tissue removed along with the abnormal cells. If these margins are found to contain abnormal cells ('positive margins'), it suggests that not all precancerous cells may have been removed during the LEEP. Similarly, a detectable HPV infection post-LEEP, even with negative margins, has been associated with a higher recurrence rate in some studies. The grade of CIN (how abnormal the cells appear under a microscope) can also play a role.
LEEP is generally considered a highly effective treatment for CIN. Studies have shown a high 'CIN cure rate,' often ranging from 73% to an impressive 99%. This means that in the vast majority of cases, LEEP successfully removes the precancerous cells. When the margins are clear (negative), the risk of CIN recurrence is very low, often reported as less than 1%. However, the presence of HPV, even with clear margins, can elevate this risk.
Besides LEEP, healthcare professionals have other methods to treat CIN:
The choice of treatment depends on various factors, including the extent and grade of CIN, as well as individual patient health.
LEEP is generally a safe procedure with a low risk of complications. Short-term risks can include reactions to anesthesia or mild discomfort. In rare cases, there might be some bleeding or infection. It's also important to be aware of potential implications for future pregnancies. While research is ongoing and sometimes conflicting, some studies suggest a possible increased risk of certain pregnancy complications after a LEEP, such as preterm delivery or premature rupture of membranes. This is often related to changes in the cervix's structure or function. Your doctor will discuss these potential risks with you.
It is essential to maintain regular follow-up appointments with your gynecologist after a LEEP procedure. Your doctor will schedule Pap smears and HPV tests to monitor for any recurrence of CIN or the development of cervical cancer. You should contact your doctor immediately if you experience any of the following:
The best approach to managing cervical health is through prevention. This includes:
By understanding the LEEP procedure, its effectiveness, potential risks, and the importance of follow-up and prevention, you can take proactive steps towards maintaining your cervical health and reducing your risk of cervical cancer.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026